Use of soluble fgl2 as an immunosuppressant
US7632495B2 · kind B2 · utility
2Cited by
2References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 28, 2003 |
| Grant date | Dec 15, 2009 |
| Priority date | — |
| Expiry date | Apr 15, 2024 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4753
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions for inducing immune suppression are disclosed. The methods involve administering an effective amount of a soluble fgl2 protein or a nucleic acid encoding a soluble fgl2 protein. The methods are useful in preventing graft rejection, autoimmune disease, and allergies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.